Literature DB >> 6213774

Sensitivity to ionising radiation of lymphocytes from Huntington's chorea patients compared to controls.

D McGovern, T Webb.   

Abstract

Blood samples were collected from 22 patients with Huntington's chorea and from 22 matched controls. Lymphocytes were separated from aliquots of each sample and cultures set up both from these and from further aliquots of whole blood. After 24 hours, half of each culture was subjected to X irradiation. Seventy-two hours later the percentages of live lymphocytes were estimated for each half of every culture and the viability ratio calculated for each sample. The lymphocytes derived from the patients with Huntington's chorea were found to be more susceptible to X irradiation than were the lymphocytes derived from controls. This was true both for whole blood and separated lymphocyte cultures. This susceptibility was found not to be the result of the main types of medication received by the patients. The small differences between viability ratios from patients and controls and the degree of overlap makes this test unsuitable for the prediction of asymptomatic carriers of the Huntington's chorea gene.

Entities:  

Mesh:

Year:  1982        PMID: 6213774      PMCID: PMC1048862          DOI: 10.1136/jmg.19.3.168

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  A linkage study of the loci for Huntington's disease and some common polymorphic markers.

Authors:  C J Brackenridge; J Case; E Chiu; D N Propert; B Teltscher; D C Wallace
Journal:  Ann Hum Genet       Date:  1978-10       Impact factor: 1.670

2.  Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.

Authors:  N V Manyam; T A Hare; L Katz; B S Glaeser
Journal:  Arch Neurol       Date:  1978-11

3.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity.

Authors:  A M Taylor; D G Harnden; C F Arlett; S A Harcourt; A R Lehmann; S Stevens; B A Bridges
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

4.  Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease.

Authors:  D A Butterfield; J Q Oeswein; W R Markesbery
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

5.  EEG in prediction of Huntington's chorea. An eighteen year follow-up.

Authors:  J H Chandler
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1966-07

6.  Use of L-dopa in the detection of presymptomatic Huntington's chorea.

Authors:  H L Klawans; G W Paulson; S P Ringel; A Barbeau
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

7.  Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.

Authors:  J H Robbins; K H Kraemer; M A Lutzner; B W Festoff; H G Coon
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

8.  Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation.

Authors:  M C Paterson; A K Anderson; B P Smith; P J Smith
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

9.  Anomalous cellular proliferation in vitro associated with Huntington's disease.

Authors:  D Kirk; J M Parrington; G Corney; J M Bolt
Journal:  Hum Genet       Date:  1977-04-15       Impact factor: 4.132

10.  Huntington's disease: delayed hypersensitivity in vitro to human central nervous system antigens.

Authors:  D S Barkley; S Hardiwidjaja; J H Menkes
Journal:  Science       Date:  1977-01-21       Impact factor: 47.728

View more
  8 in total

Review 1.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 2.  A New Perspective on Huntington's Disease: How a Neurological Disorder Influences the Peripheral Tissues.

Authors:  Laura Gómez-Jaramillo; Fátima Cano-Cano; María Del Carmen González-Montelongo; Antonio Campos-Caro; Manuel Aguilar-Diosdado; Ana I Arroba
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

3.  Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion.

Authors:  P K Liu; C Y Hsu; M Dizdaroglu; R A Floyd; Y W Kow; A Karakaya; L E Rabow; J K Cui
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

4.  Hypersensitivity to DNA-damaging agents in cultured cells from patients with Usher's syndrome and Duchenne muscular dystrophy.

Authors:  J H Robbins; D A Scudiero; F Otsuka; R E Tarone; R A Brumback; J D Wirtschafter; R J Polinsky; S F Barrett; A N Moshell; R G Scarpinato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-04       Impact factor: 10.154

5.  Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines.

Authors:  J H Robbins; F Otsuka; R E Tarone; R J Polinsky; R A Brumback; L E Nee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

6.  Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways.

Authors:  Girish C Melkani
Journal:  React Oxyg Species (Apex)       Date:  2016-09

7.  Mutations of the Huntington's disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates.

Authors:  Mélanie L Ferlazzo; Laurène Sonzogni; Adeline Granzotto; Larry Bodgi; Océane Lartin; Clément Devic; Guillaume Vogin; Sandrine Pereira; Nicolas Foray
Journal:  Mol Neurobiol       Date:  2013-11-26       Impact factor: 5.590

8.  In Vivo Radioprotective Activity of Cell-Permeable Bifunctional Antioxidant Enzyme GST-TAT-SOD against Whole-Body Ionizing Irradiation in Mice.

Authors:  Jianru Pan; Huocong He; Ying Su; Guangjin Zheng; Junxin Wu; Shutao Liu; Pingfan Rao
Journal:  Oxid Med Cell Longev       Date:  2017-07-19       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.